OptiNose (OPTN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.70. This compares to loss of $1.35 per share a year ago. These figures are ...

YARDLEY, Pa. (AP) — YARDLEY, Pa. (AP) — OptiNose Inc. (OPTN) on Wednesday reported a loss of $360,000 in its fourth quarter. The Yardley, Pennsylvania-based company said it had a loss of 3 ...

March 26, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial ...

Shares of NASDAQ OPTN opened at $9.15 on Friday. The firm has a market capitalization of $92.05 million, a price-to-earnings ratio of -2.18 and a beta of -0.30. OptiNose has a 52-week low of $4.82 ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Optinose, Inc. (NASDAQ: OPTN) to Paratek Pharmaceuticals is fair to Optinose shareholders. Under the terms of ...

Fintel reports that on March 20, 2025, Lake Street downgraded their outlook for OptiNose (NasdaqGS:OPTN) from Buy to Hold. Analyst Price Forecast Suggests 164.75% Upside As of March 19 ...

We're not here to say that Wheel of Fortune is easy. There are bright lights and sounds and that giant wheel. But sometimes, it really does seem easy. Such was the case on Tuesday night's episode ...

MONSEY, N.Y., March 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of OptiNose, Inc. (OPTN) (“OptiNose”) to Paratek ...

Over a year and a million kilometers' worth of real-world testing has returned impressive results for Spanish company Fersa's "fuel efficient wheel hub," which cuts fuel burn by at least 3% and ...

OptiNose stock opened at $9.15 on Thursday. The company has a market capitalization of $92.05 million, a PE ratio of -2.18 and a beta of -0.30. The firm has a fifty day simple moving average of $5 ...